Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Implementing and Scaling System-Level Solutions for the HRRm Testing Pathway in Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Australia, Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom
    Guideline Concordant Care and New Data for Patients with MIBC through la/mUC
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Release Date:
    Review Process:
    Use of PROS in RA
    Release Date:
    Attention-Deficit/Hyperactivity Disorder
    Release Date:
    Symptomatic Vulvovaginal Atrophy in the Postmenopausal Woman
    Release Date:
    Chronic Pain Care Outcomes
    Release Date:
    Chronic Pain Care in the Patient-Centered Medical Home
    Release Date:
    Medication-Overuse Headache (MOH)
    Release Date:
    Reducing Cardiovascular Risk Globally Through Improved Dyslipidemia Awareness and Treatment
    Release Date:
    Community Oncologist Education and Support Systems ‐ Renal Cell Carcinoma and Hematologic Malignancies
    Release Date:
    Disparities in Adult Immunizations
    Release Date:
    Global Bridges Smoking Cessation
    Release Date:
    Advances in Anticoagulation (Pfizer and BMS)
    Release Date:
    Review Process: